Status:
RECRUITING
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Myocarditis
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Magnetic properties of myocardial tissue change in the presence of disease. This is detectable in the change of rate of magnetic relaxation, and measurable by T1 and T2 mapping using cardiovascular ma...
Eligibility Criteria
Inclusion
- Able to provide informed consent
- 18 years of age and over
- Absence of a valid clinical indication for CMR, and/or known or clinically relevant cardiac disease
Exclusion
- accepted contraindications for a contrast-enhanced CMR study (in line with MRI safety and SmPC for contrast agent)
Key Trial Info
Start Date :
November 15 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2030
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT04444128
Start Date
November 15 2016
End Date
June 30 2030
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany, Frankfurt am Main